TOM-1 for the brain

This brain protein could put the brakes on Alzheimer’s

Biologists from the University of California, Irvine have made a major finding on combating inflammation linked to Alzheimer's disease.

The School of Biological Sciences researchers’ discovery about the role of a protein called TOM-1 heralds a shift toward examining the molecular underpinnings of Alzheimer’s processes. Their study appears online in Proceedings of the National Academy of Sciences. “Scientists have known for a long time that inflammation is a driver of Alzheimer’s disease, but inflammation is complex and involves many factors,” said School of Biological Sciences Dean Frank LaFerla, Ph.D., whose laboratory conducted the research. “That’s why we decided to look at TOM-1.”

Photo
Alessandra Martini and Frank LaFerla the UCI School of Biological Sciences led the study.
Source: UCI

The protein helps to regulate a key component of the inflammatory response. “We were interested in TOM-1 because its levels are low in the Alzheimer’s brain and in the brains of Alzheimer’s rodent models,” said Alessandra Martini, Ph.D., the paper’s first author and a postdoctoral researcher who worked with LaFerla. “However, its specific role in the disease has largely been unexplored.”

The scientists discovered that reducing the amount of TOM-1 in Alzheimer’s rodent models increased pathology, which included increased inflammation, and exacerbated cognitive problems associated with the disease. Restoring TOM-1 levels reversed those effects. “You can think of TOM-1 as being like the brakes of a car, and the brakes aren’t working for people with Alzheimer’s,” LaFerla said. “This research shows that fixing the brakes at the molecular level could provide an entirely new therapeutic avenue. With millions of people affected by Alzheimers and the numbers growing, we must research a diverse portfolio of approaches so we can one day vanquish this terrible disease.”


Source: University of California, Irvine

08.10.2019

Read all latest stories

Related articles

Photo

Medication development platform

Smart biomarkers to find new drugs against brain diseases

Dr. Hayder Amin and Dr. Caghan Kizil from the DZNE’s Dresden site aim to speed up developing drugs against brain diseases through cutting-edge technology. To this end, they are generating an…

Photo

Battle for the brain

New Alzheimer's treatment approach targets tau

A new idea for treating Alzheimer’s disease could eradicate the toxic proteins most closely linked to cognitive decline in the places where they do the most damage, a study from researchers at…

Photo

Tau pathology in the brain

Defining the 4 subtypes of Alzheimer's

Alzheimer's disease is characterized by the abnormal accumulation and spread of the tau protein in the brain. An international study can now show how tau spreads according to four distinct patterns…

Related products

mediaire – mdbrain

Artificial Intelligence

mediaire – mdbrain

mediaire GmbH
Sarstedt – Low DNA Binding Micro Tubes

Research Use Only (RUO)

Sarstedt – Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
Shimadzu – CLAM-2030

Research Use Only (RUO)

Shimadzu – CLAM-2030

Shimadzu Europa GmbH
Subscribe to Newsletter